title: Therapeutic effects of stem cell on hyperglycemia, hyperlipidemia, and oxidative stress in alloxan-treated rats.
abstract: Diabetes mellitus is the most common endocrine disorder that affects more than 285 million people worldwide. The purpose of this study was to investigate the effect of mesenchymal stem cells (MSCs) from the bone marrow of albino rats, on hyperglycemia, hyperlipidemia, and oxidative stress induced by intraperitoneal injection (i.p.) of alloxan at a dose of 150 mg/kg in rats. Injection of alloxan into rats resulted in a significant increase in serum glucose, total cholesterol, triglyceride, low density lipoprotein cholesterol, and sialic acid level and a significant decrease in serum insulin, high density lipoprotein-cholesterol, vitamin E, and liver glycogen as compared to their corresponding controls. Also, oxidative stress was noticed in pancreatic tissue as evidenced by a significant decrease in glutathione level, superoxide dismutase, glutathione-S-transferase activities, also a significant increase in malondialdehyde and nitric oxide levels when compared to control group. Treatment of diabetic rats with MSCs stem cells significantly prevented these alterations and attenuated alloxan-induced oxidative stress. In conclusion, rat bone marrow harbors cells that have the capacity to differentiate into functional insulin-producing cells capable of controlling hyperglycemia, hyperlipidemia, and oxidative stress in diabetic rats. This may be helpful in the prevention of diabetic complications associated with oxidative stress.
authors.affiliation: National Organization for Drug Control & Research, P.O. 29, Cairo, Egypt, wldhmdy@yahoo.com.
authors.forename: Walid Hamdy
authors.initials: WH
authors.lastname: El-Tantawy
authors.forename: Ekram Nemr Abd Al
authors.initials: EN
authors.lastname: Haleem
mesh_terms: D000496:Alloxan; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D003921:Diabetes Mellitus, Experimental / Q000097:blood / Q000473:pathology / Q000628:therapy*; D005260:Female; D005434:Flow Cytometry; D005978:Glutathione / Q000378:metabolism; D006003:Glycogen / Q000378:metabolism; D006943:Hyperglycemia / Q000150:complications / Q000628:therapy*; D006949:Hyperlipidemias / Q000150:complications / Q000628:therapy*; D007328:Insulin / Q000097:blood; D008055:Lipids / Q000097:blood; D008099:Liver / Q000378:metabolism; D008297:Male; D008315:Malondialdehyde / Q000378:metabolism; D045164:Mesenchymal Stem Cell Transplantation; D059630:Mesenchymal Stem Cells / Q000166:cytology*; D019158:N-Acetylneuraminic Acid / Q000097:blood; D009569:Nitric Oxide / Q000378:metabolism; D018384:Oxidative Stress; D010179:Pancreas / Q000378:metabolism / Q000473:pathology; D017208:Rats, Wistar; D014810:Vitamin E / Q000097:blood
chemical_list: D001786:Blood Glucose; D007328:Insulin; D008055:Lipids; D014810:Vitamin E; D009569:Nitric Oxide; D008315:Malondialdehyde; D000496:Alloxan; D006003:Glycogen; D005978:Glutathione; D019158:N-Acetylneuraminic Acid